Cipher Capital’s Integra LifeSciences IART Stock Holding History

Cipher Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$324K	Sell	9,129 -4,702	-34%	-$188K	0.15%	249
2023 Q4	$602K	Buy	13,831 +3,697	+36%	+$145K	0.2%	171
2023 Q3	$387K	Sell	10,134 -37,869	-79%	-$1.59M	0.27%	127
2023 Q2	$1.97M	Buy	48,003 +32,027	+200%	+$1.54M	0.34%	93
2023 Q1	$917K	Sell	15,976 -25,951	-62%	-$1.46M	0.17%	213
2022 Q4	$2.35M	Buy	41,927 +30,205	+258%	+$1.54M	0.44%	55
2022 Q3	$497K	Buy	+11,722	New	+$601K	0.08%	268
2020 Q3	–	Sell	-5,852	Closed	-$275K	–	569
2020 Q2	$275K	Buy	+5,852	New	+$288K	0.04%	393
2019 Q4	–	Sell	-22,019	Closed	-$1.32M	–	566
2019 Q3	$1.32M	Buy	+22,019	New	+$1.31M	0.1%	269
2017 Q2	–	Sell	-28,617	Closed	-$1.21M	–	623
2017 Q1	$1.21M	Buy	+28,617	New	+$1.22M	0.09%	351

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cipher Capital's IART Position: Q1 2024 in Review

Cipher Capital reduced its Integra LifeSciences (IART) stake by 34% in Q1 2024, selling an estimated $188K and leaving 9,129 shares worth $324K. The position accounts for 0.15% of the portfolio, ranked #249.

Cipher Capital first reported a position in IART in Q1 2017 and has held it in 10 quarters since. The position peaked at $2.35M in Q4 2022. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

Cipher Capital held 9,129 shares of Integra LifeSciences worth $324K as of Q1 2024.
Cipher Capital sold 4,702 Integra LifeSciences shares in Q1 2024, an estimated $188K.
Integra LifeSciences made up 0.15% of Cipher Capital's portfolio in Q1 2024, its #249 holding.
Cipher Capital first reported a position in Integra LifeSciences in Q1 2017 and has held it in 10 quarters since.
Cipher Capital's Integra LifeSciences position peaked at $2.35M in Q4 2022.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.